Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
about
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer: A meta-analysis
P2860
Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Proliferation rate and breast ...... ocally advanced breast cancer.
@en
Proliferation rate and breast ...... ocally advanced breast cancer.
@nl
type
label
Proliferation rate and breast ...... ocally advanced breast cancer.
@en
Proliferation rate and breast ...... ocally advanced breast cancer.
@nl
prefLabel
Proliferation rate and breast ...... ocally advanced breast cancer.
@en
Proliferation rate and breast ...... ocally advanced breast cancer.
@nl
P2093
P2860
P1433
P1476
Proliferation rate and breast ...... ocally advanced breast cancer.
@en
P2093
Amanjit Bal
Debajyoti Chatterjee
Gurpreet Singh
P2860
P2888
P304
P356
10.1007/S00428-015-1794-8
P577
2015-06-11T00:00:00Z